Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jana Pelcova"'
Autor:
Lenka Sedlarikova, Lena Kubiczkova, Fedor Kryukov, Jana Pelcova, Zdenek Adam, Ludek Pour, Roman Hajek, Sabina Sevcikova
Publikováno v:
Biomedical Papers, Vol 159, Iss 4, Pp 554-561 (2015)
Aims: Multiple myeloma (MM), the second most common hematological cancer, is a lymphoproliferative disease of terminally differentiated B lymphocytes characterized by expansion of monoclonal plasma cells. With the introduction of new drugs, MM has be
Externí odkaz:
https://doaj.org/article/979666c699f247469def1d8d33f8a5fc
Autor:
Lucie Rihova, Martin Plášil, Zdenek Adam, Karthick Raja Muthu Raja, Roman Hájek, Jana Pelcova
Publikováno v:
Cytometry Part B: Clinical Cytometry. 86:220-228
Background: Multiple myeloma (MM) is a malignancy of plasma cells frequently associated with immune abnormalities. Several studies have confirmed that in MM immune deregulation can be mediated by increased numbers of CD4 T regulatory (Treg) cells, an
Publikováno v:
American Journal of Hematology
Autor:
Lenka, Kubiczkova Besse, Lenka, Sedlarikova, Fedor, Kryukov, Jana, Nekvindova, Lenka, Radova, Martina, Almasi, Jana, Pelcova, Jiri, Minarik, Tomas, Pika, Zuzana, Pikalova, Vlastimil, Scudla, Marta, Krejci, Zdenek, Adam, Ludek, Pour, Roman, Hajek, Sabina, Sevcikova
Publikováno v:
American journal of hematology. 90(3)
Autor:
Roman Hájek, Lena Kubiczkova, Ludek Pour, Zdenek Adam, Sabina Ševčíková, Fedor Kryukov, Jana Pelcova, Lenka Sedlarikova
Publikováno v:
Biomedical Papers, Vol 159, Iss 4, Pp 554-561 (2015)
Aims: Multiple myeloma (MM), the second most common hematological cancer, is a lymphoproliferative disease of terminally differentiated B lymphocytes characterized by expansion of monoclonal plasma cells. With the introduction of new drugs, MM has be
Autor:
Jana Nekvindová, Jana Pelcova, Vlastimil Scudla, Fedor Kryukov, Lenka Sedlarikova, Jiri Minarik, Marta Krejčí, Tomas Pika, Zdenek Adam, Roman Hájek, Sabina Ševčíková, Martina Almáši, Lenka Radová, Lenka Besse, Z. Pikalová, Ludek Pour
Publikováno v:
American Journal of Hematology. 90:E51-E52
IgM monoclonal gammopathies are a group of diseases characterized by increased level of IgM immunoglobulin produced by one clone of B cells. These diseases range trom benign (monoclonal gammopathy ot undetermined significance, MGUS) to malignant, suc
Autor:
Karthick Raja Muthu Raja, Martin Plasil, Lucie Rihova, Jana Pelcova, Zdenek Adam, Roman Hajek
Publikováno v:
Cytometry Part B: Clinical Cytometry.
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e201
Publikováno v:
Blood. 122:3233-3233
Background Lenalidomide is immunomodulatory drug with a range of antineoplastic actions, it is highly effective in multiple myeloma (MM). Lenalidomide has been associated with various adverse side effects including fatigue, constipation, haematologic
Autor:
Jiri Mayer, Zdenek Adam, Ludek Pour, Lenka Zahradová, Marta Krejčí, Jana Pelcova, Roman Hájek
Publikováno v:
Blood. 120:3126-3126
Abstract 3126 Background: Autologous stem cell transplantation (ASCT) after high-dose melphalan 200mg/m2 has got an important role in the treatment of symptomatic multiple myeloma (MM). The prognostic significance of achieving complete response (CR)